Last €35.69 EUR
Change Today +0.225 / 0.63%
Volume 933.5K
GRF On Other Exchanges
Symbol
Exchange
OTC US
OTC US
NASDAQ GS
OTC US
Continuous
Continuous
Frankfurt
Frankfurt
As of 11:38 AM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas H. Glanzmann

Chairman of US Operations and Director, Grifols, S.A.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 4 different organizations across 5 different industries.

See Board Relationships
55--

Background*

Mr. Thomas H. Glanzmann serves as the Chief Executive Officer at HemoCue AB. Mr. Glanzmann serves as an Advisor to EQT and to the World Economic Forum. He served as the Chief Executive Officer and President of Gambro AB from December 2006 to January 18, 2011. He served as Senior Vice President of Baxter World Trade Corporation and Baxter Healthcare Corporation, subsidiaries of Baxter International Inc. since May 2001. Mr. Glanzmann served as President of BioScience of ...

Read Full Background

Corporate Headquarters*

Avinguda de la Generalitat, 152-158
Barcelona, Catalonia 08174

Spain

Phone: 34 935 71 22 00
Fax: 34 935 71 02 67

Board Members Memberships*

Director
2006-Present
Chairman of US Operations and Director
2011-Present
Chairman
2012-Present
Director, Member of Audit Committee and Member of Strategy Committee

Education*

MBA
IMD International
BA
Dartmouth College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRF:SM €35.69 EUR +0.225

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB SA
€2.1M
Hartmut Retzlaff Chairman of the Executive Board and Chief Executive Officer of the Executive Board
Stada-Arzneimittel AG
€3.2M
F. Michael Ball Chief Executive Officer, Director and Member of Science, Technology & Quality Committee
Hospira Inc.
$1.0M
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
$2.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRIFOLS SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.